Relative tachycardia in patients with sepsis: An independent risk factor for mortality

QJM: An International Journal of Medicine

Volumn 100, Issue 10, 2007, Pages 629-634

  Leibovici, L ^a   Gafter Gvili, A ^a   Paul, M ^a   Almanasreh, N ^b   Tacconelli, E ^c   Andreassen, S ^d   Nielsen, A D ^d   Frank, U ^b   Cauda, R ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF FREIBURG   (Germany)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC STIMULATION; ADULT; AGED; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FEVER; GERMANY; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; ISRAEL; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULSE RATE; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; UNIVERSITY HOSPITAL;

EID: 35148874145     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm074     Document Type: Article

References (14)

1. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001; 134 550-60.
2. Squire I. Neurohormonal intervention to reduce sudden cardiac death in heart failure: What is the optimal pharmacologic strategy? Heart Fail Rev 2004; 9:337-45.
3. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: Systematic review and meta-regression analysis. Br Med J 1999; 318:1730-7.
4. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: What is the actual risk reduction? Surgery 2005; 138 171-9.
5. Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, Takeda J. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 2005; 33:2294-301.
6. Aderka D, Sclarovsky S, Lewin RF, Arditti A, Agmon J, Pinkhas J. Life-threatening ventricular arrhythmias in septicemia. Isr J Med Sci 1984; 20:535-7.
7. Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M, Roth E, Fugger R. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 1999; 12 421-7.
8. Dickerson RN, Fried RC, Bailey PM, Stein TP, Mullen JL, Buzby GP. Effect of propranolol on nitrogen and energy metabolism in sepsis. J Surg Res 1990; 48:38-41.
9. Herndon DN, Barrow RE, Rutan TC, Minifee P, Jahoor F, Wolfe RR. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg 1988; 208:484-92.
10. Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, Cauda R, Leibovici L, on behalf of the TREAT Study Group. Improving empirical antibiotic treatment using TREAT, a computerised decision support system: Cluster randomised trial. J Antimicrob Chemother 2006; 58:1238-45.
11. Paul M, Andreassen S, Nielsen AD, Tacconelli E, Almanasreh N, Fraser A, Yahav D, Ram R, Leibovici L; the TREAT Study Group. Prediction of Bacteremia Using TREAT, a Computerized Decision-Support System. Clin Infect Dis 2006; 42:1274-82.
12. Bone RC, Balk RA, Cerra-FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
14. Meldrum DR. Beta-blockade during sepsis: Inspired or insane? Crit Care Med 2005; 33:2433-4.